Avanos Medical Inc (AVNS)
Fixed asset turnover
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 687,800 | 681,500 | 682,400 | 680,100 | 705,700 | 749,900 | 780,700 | 814,300 | 820,000 | 795,900 | 777,900 | 761,300 | 744,600 | 736,200 | 737,800 | 715,100 | 714,800 | 719,600 | 705,300 | 713,800 |
Property, plant and equipment | US$ in thousands | — | — | — | — | — | 143,900 | 122,600 | 163,500 | 163,900 | 163,400 | 198,200 | 166,900 | 168,100 | 169,700 | 214,800 | 173,400 | 175,300 | 177,300 | 179,300 | 178,700 |
Fixed asset turnover | — | — | — | — | — | 5.21 | 6.37 | 4.98 | 5.00 | 4.87 | 3.92 | 4.56 | 4.43 | 4.34 | 3.43 | 4.12 | 4.08 | 4.06 | 3.93 | 3.99 |
December 31, 2024 calculation
Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $687,800K ÷ $—K
= —
The fixed asset turnover ratio of Avanos Medical Inc has exhibited fluctuations over the past few years. The ratio measures the efficiency of the company in generating revenue from its investment in fixed assets.
From March 2020 to June 2022, the fixed asset turnover ratio ranged between 3.93 and 4.56, indicating that for every dollar invested in fixed assets, the company generated between $3.93 and $4.56 in sales revenue. This suggests that Avanos was effectively utilizing its fixed assets to generate revenue during this period.
In the subsequent periods, the ratio showed more variability, with a notable decline to 3.43 in June 2021 before rebounding to 6.37 in June 2023. The sharp increase in June 2023 signifies a significant improvement in the efficiency of utilizing fixed assets to generate revenue.
As of the latest available data in December 2023, the fixed asset turnover ratio stood at 5.21, demonstrating continued efficiency in asset utilization. However, data is missing for the following periods, making it difficult to assess the trend beyond 2023.
Overall, the analysis of Avanos Medical Inc's fixed asset turnover indicates fluctuations in the company's ability to generate sales from its investment in fixed assets, with periods of both efficiency and volatility.
Peer comparison
Dec 31, 2024